ASSOCIATION OF ADRA2B POLYMORPHISM WITH RISK FACTORS FOR CARDIOVASCULAR DISEASES IN NATIVE POPULATION OF MOUNTAIN SHORIA

Study objectives: examine the frequency of genotypes and alleles of I/D polymorphism of gene ADRA2B of native people living in Mountain Shoria (the Shors), as well as their association with risk factors for cardiovascular diseases.
Material and methods. Overall 221 native people of Shoria were examined. The average age is
51.07 ± 1.46 among males, 52.93 ± 0.96 among females (p = 0.286). Anthropometric characteristics, lipid levels of blood and I/D polymorphism of ADRA2B were studied.
Results. DD genotype of the gene ADRA2B in the native population of the Shor people is associated with adiposis and high index of "waist/hip", hypertriglyceridemia. The average values of Quetelet index is higher in carriers of this genotype compared with carriers of genotype ID. Average waist indications in homozygous insertions were lower than those in homozygous deletions and heterozygotes. Patients with genotype DD have higher average levels of triglycerides, atherogenic index, cholesterol, very low density lipoproteins.
Conclusion. DD allele ADRA2B genotype is responsible for adiposis and high levels of TG among native population of Shoria.

1. Boytsov S.A. [Ten years of searching for the genetic basis ofhypertension: challenges and prospects]. Arterialnaya gipertenzya – Hypertension, 2004, vol. 8, no. 3, pp. 157–160.

2. Karpov R.S., Puzyrev K.V., Pavlyukova E.N., Stepanov V.A. [Molecular genetic analysis of left ventricular hypertrophy]. Kardiologiya – Cardiology, 2001, no. 6, pp. 25–30.

3. Ryazanov A.S., Kelyants A.A., Yurenev A.P. [Hypertensive heart. Status of the problem]. Klinicheskaya medicina – Clinical Medicine, 2003, no. 6, pp. 15–18.

4. Ham J., Rees D.A. The adenosine a2b receptor: its role in inflammation. Endocr. Metab. Immune Disord Drug Targets, 2008, 8 (4), pp. 244–254.

5. Snapir A., Heinonen P., Tuomainen T.P. et al. An inse rtion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J. Am. Coll. Cardiol., 2001, 37 (6), pp. 1516– 1522.

6. Link R.E., Desai K., Hein L. et al. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science, 1996, 273 (5276), pp. 803–805.

7. Etzel J.P., Rana B.K., Wen G. et al. Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response. Hypertension, 2005, 45 (6), pp. 1207–1213.

8. Wolff B., Grabe H.J., Schluter C. et al. Endothelial nitric oxide synthase Glu298Asp gene polymorphism, blood pressure and hypertension in a general population sample. Journal of hypertension, 2005, vol. 23, no. 7, pp. 1361–1366.

9. Heinemann P., Koulu M., Pesonen U. et al. Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J. Clin. Endocrinol. Metab., 1999, 84 (7), pp. 2429–33.

10. Wowern F., Bengtsson K., Lindblad U. et al. Functional Variant in the alpha 2B Adrenoceptor Gene, a Positional Candidate on Chromosome 2, Associates With Hypertension. Hypertension, 2004, vol. 43, no. 3, pp. 592–597.

11. Snapir A., Scheinin M., Groop L.C., Orho-Melander M. The insertion/deletion variation in the α2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes. Cardiovasc. Diabetol., 2003, 24 (2), p. 15.

12. Voevoda M.I., Yudin N.S., Maksimov V.N. et al. Veuvlenya genov predraspologenosti k rasprostranennm serdechnososudisthem zabolevaniam principw, dostigenia I perspectivy [Identification of susceptibility genes for common cardiovascular disease principles, achievements and prospects. Molecular biological technologies in medical practice]. Novosibirsk, 2006. Pp. 16–23.

13. Voevoda M.I., Maksimov V.N., Kulikov I.V. et al. Vnezapnaya serdechno sosudistaya smert i polymorfizm genov-kanditov serdechno-sosudistyh zabolevany [Sudden cardiac death and polymorphism of candidate genes for cardiovascular disease MEA]. Novosibirsk, 2006. Pp. 23–27.

14. Baldwin C.T., Schwartz F., Baima J. et al. Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertension. Am. J. Hypertens., 1999, 12 (9), pp. 853–857.

15. Vasudevan R., Ismail P., Stanslas J. et al. Association of Insertion/Deletion Polymorphism of Alpha-Adrenoceptor Gene in Essential Hypertension with or without Type 2 Diabetes Mellitus in Malaysian Subjects. Int. J. Biol. Sci., 2008, 4 (6), pp. 362–367.

16. Zhang H., Li X., Huang J., Li Y., Thijs L. et al. Cardiovascular and metabolic phenotypes in relation to the ADRA2B insertion/deletion polymorphism in a Chinese population. J. Hypertens., 2005, 23 (12), pp. 2201–2207.